<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03225313</url>
  </required_header>
  <id_info>
    <org_study_id>722014</org_study_id>
    <nct_id>NCT03225313</nct_id>
  </id_info>
  <brief_title>Comparison Between Ultra Sound Guided Rectus Sheath Block and Field Block for Midline Hernia Repair</brief_title>
  <official_title>Ultra Sound Guided Rectus Sheath Block or Field Block for Midline Hernia Repair: A Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theodor Bilharz Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theodor Bilharz Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized double blinded controlled clinical trial will be done with a total number of 75
      patients will be divided into 3 groups. To compare between Ultra-sound guided rectus sheath
      block VS Field block infiltration in providing a good analgesia for patients undergoing
      midline hernia repair to detect which one is superior.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      75 patients undergoing midline hernia repair under general anesthesia will be recruited and
      will be randomly allocated using closed envelope technique as follows: Control group, Local
      infilteration (Field block infilteration) group, Ultra sound Guided Rectus sheath block
      group.

      General anesthesia will be standardized for all patients with :

      2 Âµg kg-1 fentanyl and 2 mg kg-1 propofol. Neuromuscular blockade will be achieved with 0.5
      mg kg-1 atracurium followed by tracheal intubation.

      Muscle relaxation will be maintained by 0.1mg / kg / 30 minute of Atracrurium. Anesthesia
      will be maintained by sevoflurane. Mechanical ventilation will be adjusted with fresh gas
      flow oxygen in air 30-50% at a rate of 1 L min-1to maintain end-tidal carbon dioxide of 35-40
      mm Hg and Spo2 greater than 94%.

      BIS values will be maintained between 40 and 60. All surgical procedures will be done in the
      range between 10 am and 1 pm and by the same surgical team.

        1. Control group : will receive field block using 0.3 ml/kg of normal saline at site of the
           hernia plus ultra- sound guided rectus sheath injection using 0.3 ml / kg of normal
           saline.

        2. Field block group: will receive 0.3 ml / kg of 0.5% bupivicaine subcutaneously
           surrounding the site of the hernia following the induction of anesthesia and ultra-sound
           guided rectus sheath block with 0.3 ml / kg of normal saline.

        3. Ultrasound guided rectus sheath block : Under sterile conditions a 21/22 G , 50- 100
           milli meter length echogenic needle guided by the ultrasound into rectus sheath at the
           level of the umbilicus , using an - in plane technique. After -ve aspiration 0.3 ml/ kg
           of 0.5 % bupivicaine will be deposited on each side and the spread of local anesthesia
           will be observed by ultrasound plus 0.3 ml/kg of normal saline subcutaneously at the
           site of the hernia.

      All solutions used will be prepared by a colleague who will not participate into the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 20, 2016</start_date>
  <completion_date type="Actual">March 20, 2017</completion_date>
  <primary_completion_date type="Actual">October 20, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immediate Postoperative Pain</measure>
    <time_frame>evaluation of postoperative pain in patients immediately after the procedure.</time_frame>
    <description>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Pain at 2 Hours After Procedure.</measure>
    <time_frame>evaluation of postoperative pain in patients at 2 hours after procedure.</time_frame>
    <description>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Pain at 6 Hours After Procedure.</measure>
    <time_frame>Evaluation of postoperative pain in patients at 6 hours after procedure.</time_frame>
    <description>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the Level of Serum Cortisol.</measure>
    <time_frame>Measurement of serum cortisol level (nmol/ liter) using the ELISA technique after 1 hour of the start of the surgery.</time_frame>
    <description>Measurement of serum cortisol level (nmol/ liter) using the ELISA technique after 1 hour of the start of the surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Serum Adrenaline Levels (ng/ml) Using ELISA Technique.</measure>
    <time_frame>1 hour after the start of the surgery using ELISA technique.</time_frame>
    <description>Measurement of serum adrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Serum Noradrenaline Levels (ng/ml) Using ELISA Technique.</measure>
    <time_frame>1 hour after the start of the surgery</time_frame>
    <description>Measurement of serum noradrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Serum Cortisol Level (Nmol/ Liter) Using ELISA Technique.</measure>
    <time_frame>30 minutes before the start of the surgery</time_frame>
    <description>Measurement of serum cortisol level (nmol/ liter) using ELISA technique 30 minutes before the start of the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Serum Adrenaline Level (ng/ml) Using ELISA Technique.</measure>
    <time_frame>30 minutes before the start of the surgery</time_frame>
    <description>Measurement of serum adrenaline level (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of Serum Noradrenaline Levels (ng/ml) Using ELISA Technique.</measure>
    <time_frame>30 minutes before the start of the surgery.</time_frame>
    <description>Measurement of serum noradrenaline levels (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Ultrasound Guided Rectus Sheath Block</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline will be injected in the rectus sheath</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rectus block group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bupivicaine will be injected in the rectus sheath</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Field block group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bupivicaine will be injected locally in a circular fashion surrounding the site of the hernia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride 0.5% Injection Solution_#4</intervention_name>
    <description>ultra sound guided injection into the rectus sheath</description>
    <arm_group_label>Rectus block group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline Flush, 0.9% Injectable Solution_#5</intervention_name>
    <description>injected into rectus sheath using ultrasound &amp; locally surrounding the hernia</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride 0.5% Injection Solution_#4</intervention_name>
    <description>locally surrounding the hernia</description>
    <arm_group_label>Field block group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Elective midline hernia repair surgery.

          2. Age: adult patients between 18 - 60 years old.

          3. Gender: Both male and female.

          4. ASA Class: I &amp; II.

        Exclusion Criteria:

          1. Refusal of patient.

          2. Pregnancy and lactation.

          3. Fever or sepsis.

          4. Patients ASA III or IV.

          5. Addicts and drug abusers.

          6. Patients taking corticosteroids or any cardio - active drugs.

          7. Local infection at site of the injection.

          8. Allergy to any of the study medications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mohammed ma hussein, lecturer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Theodor Bilharz Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Theodor Bilharz Research Institute</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 10, 2017</study_first_submitted>
  <study_first_submitted_qc>July 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2017</study_first_posted>
  <results_first_submitted>January 24, 2019</results_first_submitted>
  <results_first_submitted_qc>April 21, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 11, 2019</results_first_posted>
  <last_update_submitted>July 24, 2019</last_update_submitted>
  <last_update_submitted_qc>July 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Theodor Bilharz Research Institute</investigator_affiliation>
    <investigator_full_name>Mohamed Hussein</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia and Surgical intensive care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>ASA I &amp; II patients. 25 patient in each group.</recruitment_details>
      <pre_assignment_details>Prospective randomized double blinded controlled clinical trial was done with a total number of 75 patients divided into 3 groups .</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
        </group>
        <group group_id="P2">
          <title>Ultra- Sound Rectus Sheath Block Group</title>
          <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
        </group>
        <group group_id="P3">
          <title>Local Infilteration Group</title>
          <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25">25 Patients</participants>
                <participants group_id="P2" count="25">25 Patients</participants>
                <participants group_id="P3" count="25">25 Patients</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25">25 Patients</participants>
                <participants group_id="P2" count="25">25 Patients</participants>
                <participants group_id="P3" count="25">25 Patients</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>count of participants</population>
      <group_list>
        <group group_id="B1">
          <title>Control Group</title>
          <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
        </group>
        <group group_id="B2">
          <title>Ultra- Sound Rectus Sheath Block Group</title>
          <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
        </group>
        <group group_id="B3">
          <title>Local Infilteration Group</title>
          <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="75"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.80" spread="9.941"/>
                    <measurement group_id="B2" value="42.20" spread="10.464"/>
                    <measurement group_id="B3" value="44.08" spread="8.544"/>
                    <measurement group_id="B4" value="43.76" spread="9.606"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Egypt</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Weight in Kilograms</title>
          <units>Kilogram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82.7" spread="13.9"/>
                    <measurement group_id="B2" value="83.7" spread="11.8"/>
                    <measurement group_id="B3" value="82" spread="10.6"/>
                    <measurement group_id="B4" value="82.87" spread="12.115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Immediate Postoperative Pain</title>
        <description>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</description>
        <time_frame>evaluation of postoperative pain in patients immediately after the procedure.</time_frame>
        <population>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
          </group>
          <group group_id="O2">
            <title>Ultra- Sound Rectus Sheath Block Group</title>
            <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
          </group>
          <group group_id="O3">
            <title>Local Infilteration Group</title>
            <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
          </group>
        </group_list>
        <measure>
          <title>Immediate Postoperative Pain</title>
          <description>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</description>
          <population>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.36" spread="2.691"/>
                    <measurement group_id="O2" value="1.04" spread="1.837"/>
                    <measurement group_id="O3" value="6.56" spread="3.029"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Pain at 2 Hours After Procedure.</title>
        <description>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</description>
        <time_frame>evaluation of postoperative pain in patients at 2 hours after procedure.</time_frame>
        <population>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
          </group>
          <group group_id="O2">
            <title>Ultra- Sound Rectus Sheath Block Group</title>
            <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
          </group>
          <group group_id="O3">
            <title>Local Infilteration Group</title>
            <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain at 2 Hours After Procedure.</title>
          <description>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</description>
          <population>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.04" spread="1.645"/>
                    <measurement group_id="O2" value="1.20" spread="1.826"/>
                    <measurement group_id="O3" value="5.12" spread="1.833"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Pain at 6 Hours After Procedure.</title>
        <description>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</description>
        <time_frame>Evaluation of postoperative pain in patients at 6 hours after procedure.</time_frame>
        <population>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
          </group>
          <group group_id="O2">
            <title>Ultra- Sound Rectus Sheath Block Group</title>
            <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
          </group>
          <group group_id="O3">
            <title>Local Infilteration Group</title>
            <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain at 6 Hours After Procedure.</title>
          <description>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</description>
          <population>Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.28" spread="2.011"/>
                    <measurement group_id="O2" value="2.64" spread="1.497"/>
                    <measurement group_id="O3" value="5.16" spread="2.304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Level of Serum Cortisol.</title>
        <description>Measurement of serum cortisol level (nmol/ liter) using the ELISA technique after 1 hour of the start of the surgery.</description>
        <time_frame>Measurement of serum cortisol level (nmol/ liter) using the ELISA technique after 1 hour of the start of the surgery.</time_frame>
        <population>Measurement of serum cortisol level (nmol/ liter) using the ELISA technique after 1 hour of the start of the surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
          </group>
          <group group_id="O2">
            <title>Rectus Block Group</title>
            <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
          </group>
          <group group_id="O3">
            <title>Local Group</title>
            <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Level of Serum Cortisol.</title>
          <description>Measurement of serum cortisol level (nmol/ liter) using the ELISA technique after 1 hour of the start of the surgery.</description>
          <population>Measurement of serum cortisol level (nmol/ liter) using the ELISA technique after 1 hour of the start of the surgery.</population>
          <units>nmol/ liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="307.84" spread="220.569"/>
                    <measurement group_id="O2" value="214.00" spread="148.198"/>
                    <measurement group_id="O3" value="286.92" spread="225.404"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measurement of Serum Adrenaline Levels (ng/ml) Using ELISA Technique.</title>
        <description>Measurement of serum adrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</description>
        <time_frame>1 hour after the start of the surgery using ELISA technique.</time_frame>
        <population>Measurement of serum adrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
          </group>
          <group group_id="O2">
            <title>Ultra- Sound Rectus Sheath Block Group</title>
            <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
          </group>
          <group group_id="O3">
            <title>Local Infilteration Group</title>
            <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
          </group>
        </group_list>
        <measure>
          <title>Measurement of Serum Adrenaline Levels (ng/ml) Using ELISA Technique.</title>
          <description>Measurement of serum adrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</description>
          <population>Measurement of serum adrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.508" spread="1.2530"/>
                    <measurement group_id="O2" value="2.556" spread="1.4030"/>
                    <measurement group_id="O3" value="2.704" spread="1.1264"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measurement of Serum Noradrenaline Levels (ng/ml) Using ELISA Technique.</title>
        <description>Measurement of serum noradrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</description>
        <time_frame>1 hour after the start of the surgery</time_frame>
        <population>Measurement of serum noradrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
          </group>
          <group group_id="O2">
            <title>Ultra- Sound Rectus Sheath Block Group</title>
            <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
          </group>
          <group group_id="O3">
            <title>Local Infilteration Group</title>
            <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
          </group>
        </group_list>
        <measure>
          <title>Measurement of Serum Noradrenaline Levels (ng/ml) Using ELISA Technique.</title>
          <description>Measurement of serum noradrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</description>
          <population>Measurement of serum noradrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique.</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.088" spread="4.6656"/>
                    <measurement group_id="O2" value="17.380" spread="9.0959"/>
                    <measurement group_id="O3" value="15.920" spread="7.3389"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measurement of Serum Cortisol Level (Nmol/ Liter) Using ELISA Technique.</title>
        <description>Measurement of serum cortisol level (nmol/ liter) using ELISA technique 30 minutes before the start of the surgery</description>
        <time_frame>30 minutes before the start of the surgery</time_frame>
        <population>Measurement of serum cortisol level (nmol/ liter) using ELISA technique 30 minutes before the start of the surgery</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
          </group>
          <group group_id="O2">
            <title>Ultra- Sound Rectus Sheath Block Group</title>
            <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
          </group>
          <group group_id="O3">
            <title>Local Infilteration Group</title>
            <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
          </group>
        </group_list>
        <measure>
          <title>Measurement of Serum Cortisol Level (Nmol/ Liter) Using ELISA Technique.</title>
          <description>Measurement of serum cortisol level (nmol/ liter) using ELISA technique 30 minutes before the start of the surgery</description>
          <population>Measurement of serum cortisol level (nmol/ liter) using ELISA technique 30 minutes before the start of the surgery</population>
          <units>nmol/ liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="159.02" spread="119.455"/>
                    <measurement group_id="O2" value="327.05" spread="215.569"/>
                    <measurement group_id="O3" value="170.52" spread="91.421"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measurement of Serum Adrenaline Level (ng/ml) Using ELISA Technique.</title>
        <description>Measurement of serum adrenaline level (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</description>
        <time_frame>30 minutes before the start of the surgery</time_frame>
        <population>Measurement of serum adrenaline level (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
          </group>
          <group group_id="O2">
            <title>Ultra- Sound Rectus Sheath Block Group</title>
            <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
          </group>
          <group group_id="O3">
            <title>Local Infilteration Group</title>
            <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
          </group>
        </group_list>
        <measure>
          <title>Measurement of Serum Adrenaline Level (ng/ml) Using ELISA Technique.</title>
          <description>Measurement of serum adrenaline level (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</description>
          <population>Measurement of serum adrenaline level (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.42" spread="0.774"/>
                    <measurement group_id="O2" value="3.96" spread="2.262"/>
                    <measurement group_id="O3" value="2.00" spread="1.416"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measurement of Serum Noradrenaline Levels (ng/ml) Using ELISA Technique.</title>
        <description>Measurement of serum noradrenaline levels (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</description>
        <time_frame>30 minutes before the start of the surgery.</time_frame>
        <population>Measurement of serum noradreline levels (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
          </group>
          <group group_id="O2">
            <title>Ultra- Sound Rectus Sheath Block Group</title>
            <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
          </group>
          <group group_id="O3">
            <title>Local Infilteration Group</title>
            <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
          </group>
        </group_list>
        <measure>
          <title>Measurement of Serum Noradrenaline Levels (ng/ml) Using ELISA Technique.</title>
          <description>Measurement of serum noradrenaline levels (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</description>
          <population>Measurement of serum noradreline levels (ng/ml) using ELISA technique 30 minutes before the start of the surgery.</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.960" spread="4.2880"/>
                    <measurement group_id="O2" value="20.880" spread="10.5235"/>
                    <measurement group_id="O3" value="12.932" spread="6.4223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours after giving the local anaesthesia</time_frame>
      <desc>Cardiac arrhythmia.</desc>
      <group_list>
        <group group_id="E1">
          <title>Control Group</title>
          <description>normal saline will be injected in the rectus sheath
Normal saline: injected into rectus sheath &amp; locally</description>
        </group>
        <group group_id="E2">
          <title>Ultra- Sound Rectus Sheath Block Group</title>
          <description>bupivicaine will be injected in the rectus sheath
Bupivacaine Hydrochloride: ultra sound guided injection into the rectus sheath</description>
        </group>
        <group group_id="E3">
          <title>Local Infilteration Group</title>
          <description>bupivicaine will be injected locally
Bupivacaine Hydrochloride: injected locally</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Muhammed Hussein</name_or_title>
      <organization>Theodor Bilharz Research Institute</organization>
      <phone>00201001434459</phone>
      <email>muhamed.hussein@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

